Computational disease subtyping

Computational Disease Subtyping enters the Adult Cognitive Disease corpus through the work of Chi U Seak (submission 150), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Chi U Seak's submission is summarised in this corpus as:

AD is not a single disease but a catalog of diseases with common cognitive symptoms. Failed clinical trials may have targeted only specific AD subtypes, and revisiting these trials with patient subtyping could reveal effective treatments for particular AD types.

Its declared subject matter: disease-subtypes, personalized-medicine, clinical-trial-failure, machine-learning, biomarker-classification, PCA, precision-medicine, AD-heterogeneity.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: AD as multiple diseases · Precision medicine approach · Revisiting failed drug trials.


Assembled from the corpus rather than written: the summary is quoted from the submission that named it. It has not yet been expanded into an article.

Last reviewed 15 August 2026.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

827 interlinked articles · 120 papers in full · 53 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.